These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 29344150)
1. Expression of CD24 and B7-H3 in breast cancer and the clinical significance. Cong F; Yu H; Gao X Oncol Lett; 2017 Dec; 14(6):7185-7190. PubMed ID: 29344150 [TBL] [Abstract][Full Text] [Related]
2. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy. Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830 [TBL] [Abstract][Full Text] [Related]
3. B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer. Xu H; Chen X; Tao M; Chen K; Chen C; Xu G; Li W; Yuan S; Mao Y Oncol Lett; 2016 Mar; 11(3):1841-1846. PubMed ID: 26998087 [TBL] [Abstract][Full Text] [Related]
4. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494 [TBL] [Abstract][Full Text] [Related]
5. RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer. Zheng C; Yang R J BUON; 2019; 24(2):715-719. PubMed ID: 31128028 [TBL] [Abstract][Full Text] [Related]
6. Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis. Benzon B; Zhao SG; Haffner MC; Takhar M; Erho N; Yousefi K; Hurley P; Bishop JL; Tosoian J; Ghabili K; Alshalalfa M; Glavaris S; Simons BW; Tran P; Davicioni E; Karnes RJ; Boudadi K; Antonarakis ES; Schaeffer EM; Drake CG; Feng F; Ross AE Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):28-35. PubMed ID: 27801901 [TBL] [Abstract][Full Text] [Related]
7. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. Zhang T; Wang F; Wu JY; Qiu ZC; Wang Y; Liu F; Ge XS; Qi XW; Mao Y; Hua D World J Gastroenterol; 2018 Aug; 24(31):3538-3546. PubMed ID: 30131660 [TBL] [Abstract][Full Text] [Related]
8. Expression of CYP1B1 and B7-H3 significantly correlates with poor prognosis in colorectal cancer patients. Liu X; Wang F; Wu J; Zhang T; Liu F; Mao Y; Hua D Int J Clin Exp Pathol; 2018; 11(5):2654-2664. PubMed ID: 31938380 [TBL] [Abstract][Full Text] [Related]
9. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis. Xu YH; Zhang GB; Wang JM; Hu HC Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas. Zhan S; Liu Z; Zhang M; Guo T; Quan Q; Huang L; Guo L; Cao L; Zhang X Front Oncol; 2019; 9():1466. PubMed ID: 31998637 [No Abstract] [Full Text] [Related]
11. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma. Mao Y; Sun J; Wang WP; Zhang XG; Hua D Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607 [TBL] [Abstract][Full Text] [Related]
12. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration. Kim GE; Kim NI; Park MH; Lee JS Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739 [TBL] [Abstract][Full Text] [Related]
13. The expressions and significance of B7-H3 and CTLA-4 in the clinical stages of non-small-cell lung cancer. Liu Z; Pei MM; Liu JX; Shi F; Zhang Y; Zhao DF; Li JM; Guo FR; Yan JJ; Liu JQ; Li YP Int J Clin Exp Pathol; 2019; 12(8):3032-3041. PubMed ID: 31934142 [TBL] [Abstract][Full Text] [Related]
14. B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma. Cheng R; Chen Y; Zhou H; Wang B; Du Q; Chen Y APMIS; 2018 May; 126(5):396-402. PubMed ID: 29696716 [TBL] [Abstract][Full Text] [Related]
15. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients. Pizon M; Schott DS; Pachmann U; Pachmann K Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585 [TBL] [Abstract][Full Text] [Related]
16. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Li B; Shao Q; Ji D; Li F; Guo X; Chen G Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637 [TBL] [Abstract][Full Text] [Related]
17. B7-H3 expression in breast cancer and upregulation of VEGF through gene silence. Sun J; Guo YD; Li XN; Zhang YQ; Gu L; Wu PP; Bai GH; Xiao Y Onco Targets Ther; 2014; 7():1979-86. PubMed ID: 25378933 [TBL] [Abstract][Full Text] [Related]
18. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161 [TBL] [Abstract][Full Text] [Related]
19. Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer. Xu L; Ding X; Tan H; Qian J Cancer Cell Int; 2013 Aug; 13(1):81. PubMed ID: 23947693 [TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of costimulatory molecule B7-H3 mRNA and B7-H3 protein in gastric carcinoma]. Zhao JM; Wu CP; Wang RC; Xu J; Zhu J; Wei J; Luo GH; Shi LR; Tan M; Tan Y Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):458-62. PubMed ID: 17851789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]